Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway.

Rogowski M, Bellusci L, Sabatini M, Rapposelli S, Rahman SM, Chiellini G, Assadi-Porter FM.

Int J Mol Sci. 2019 Aug 20;20(16). pii: E4054. doi: 10.3390/ijms20164054.

2.

Shifts in metabolic fuel use coincide with maximal rates of ventilation and body surface rewarming in an arousing hibernator.

Regan MD, Chiang E, Martin SL, Porter WP, Assadi-Porter FM, Carey HV.

Am J Physiol Regul Integr Comp Physiol. 2019 Jun 1;316(6):R764-R775. doi: 10.1152/ajpregu.00379.2018. Epub 2019 Apr 10.

PMID:
30969844
3.

Effects of Repeated Sublethal External Exposure to Deep Water Horizon Oil on the Avian Metabolome.

Dorr BS, Hanson-Dorr KC, Assadi-Porter FM, Selen ES, Healy KA, Horak KE.

Sci Rep. 2019 Jan 23;9(1):371. doi: 10.1038/s41598-018-36688-3.

4.

Multimodal Ligand Binding Studies of Human and Mouse G-Coupled Taste Receptors to Correlate Their Species-Specific Sweetness Tasting Properties.

Assadi-Porter FM, Radek J, Rao H, Tonelli M.

Molecules. 2018 Oct 3;23(10). pii: E2531. doi: 10.3390/molecules23102531.

5.

Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.

Assadi-Porter FM, Reiland H, Sabatini M, Lorenzini L, Carnicelli V, Rogowski M, Selen Alpergin ES, Tonelli M, Ghelardoni S, Saba A, Zucchi R, Chiellini G.

Int J Mol Sci. 2018 May 22;19(5). pii: E1535. doi: 10.3390/ijms19051535.

6.

The Hibernator Microbiome: Host-Bacterial Interactions in an Extreme Nutritional Symbiosis.

Carey HV, Assadi-Porter FM.

Annu Rev Nutr. 2017 Aug 21;37:477-500. doi: 10.1146/annurev-nutr-071816-064740. Epub 2017 Jul 17. Review.

PMID:
28715992
7.

Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells.

Rogowski M, Gollahon L, Chellini G, Assadi-Porter FM.

FEBS Open Bio. 2017 Mar 6;7(4):587-601. doi: 10.1002/2211-5463.12205. eCollection 2017 Apr. Erratum in: FEBS Open Bio. 2017 May 22;7(6):887.

8.

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine.

Selen Alpergin ES, Bolandnazar Z, Sabatini M, Rogowski M, Chiellini G, Zucchi R, Assadi-Porter FM.

Physiol Rep. 2017 Jan;5(1). pii: e13097. doi: 10.14814/phy2.13097.

9.

Structure-function relationships of brazzein variants with altered interactions with the human sweet taste receptor.

Singarapu KK, Tonelli M, Markley JL, Assadi-Porter FM.

Protein Sci. 2016 Mar;25(3):711-9. doi: 10.1002/pro.2870. Epub 2016 Jan 9.

10.

NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.

Selen ES, Bolandnazar Z, Tonelli M, Bütz DE, Haviland JA, Porter WP, Assadi-Porter FM.

J Proteome Res. 2015 Aug 7;14(8):3284-91. doi: 10.1021/acs.jproteome.5b00307. Epub 2015 Jul 6.

11.

NMRFAM-SDF: a protein structure determination framework.

Dashti H, Lee W, Tonelli M, Cornilescu CC, Cornilescu G, Assadi-Porter FM, Westler WM, Eghbalnia HR, Markley JL.

J Biomol NMR. 2015 Aug;62(4):481-95. doi: 10.1007/s10858-015-9933-8. Epub 2015 Apr 22.

12.

Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome.

Whigham LD, Butz DE, Dashti H, Tonelli M, Johnson LK, Cook ME, Porter WP, Eghbalnia HR, Markley JL, Lindheim SR, Schoeller DA, Abbott DH, Assadi-Porter FM.

Curr Metabolomics. 2014;2(4):269-278.

13.

Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine.

Ghanian Z, Maleki S, Reiland H, Bütz DE, Chiellini G, Assadi-Porter FM, Ranji M.

Exp Biol Med (Maywood). 2014 Feb;239(2):151-8. doi: 10.1177/1535370213510252. Epub 2013 Dec 3. Erratum in: Exp Biol Med (Maywood). 2014 Jun;239(6):770. Porter, Fariba-Assadi [corrected to Assadi-Porter, Fariba M].

14.

Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptors.

Simon BR, Parlee SD, Learman BS, Mori H, Scheller EL, Cawthorn WP, Ning X, Gallagher K, Tyrberg B, Assadi-Porter FM, Evans CR, MacDougald OA.

J Biol Chem. 2013 Nov 8;288(45):32475-89. doi: 10.1074/jbc.M113.514034. Epub 2013 Sep 24.

15.

Temperature-dependent conformational change affecting Tyr11 and sweetness loops of brazzein.

Cornilescu CC, Cornilescu G, Rao H, Porter SF, Tonelli M, DeRider ML, Markley JL, Assadi-Porter FM.

Proteins. 2013 Jun;81(6):919-25. doi: 10.1002/prot.24259. Epub 2013 Feb 25.

16.

Use of NMR saturation transfer difference spectroscopy to study ligand binding to membrane proteins.

Venkitakrishnan RP, Benard O, Max M, Markley JL, Assadi-Porter FM.

Methods Mol Biol. 2012;914:47-63. doi: 10.1007/978-1-62703-023-6_4.

17.

Efficient stable isotope labeling and purification of vitamin D receptor from inclusion bodies.

Zhu J, Rao H, Tonelli M, Westler WM, Singarapu KK, Markley JL, DeLuca HF, Assadi-Porter FM.

Protein Expr Purif. 2012 Sep;85(1):25-31. doi: 10.1016/j.pep.2012.06.012. Epub 2012 Jun 29.

18.

Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets.

Kim J, Breunig MJ, Escalante LE, Bhatia N, Denu RA, Dollar BA, Stein AP, Hanson SE, Naderi N, Radek J, Haughy D, Bloom DD, Assadi-Porter FM, Hematti P.

Cytotherapy. 2012 Sep;14(8):925-35. doi: 10.3109/14653249.2012.684376. Epub 2012 May 9.

19.

Novel diagnostics of metabolic dysfunction detected in breath and plasma by selective isotope-assisted labeling.

Haviland JA, Tonelli M, Haughey DT, Porter WP, Assadi-Porter FM.

Metabolism. 2012 Aug;61(8):1162-70. doi: 10.1016/j.metabol.2011.12.010. Epub 2012 Feb 2.

20.

Ligand-specific structural changes in the vitamin D receptor in solution.

Singarapu KK, Zhu J, Tonelli M, Rao H, Assadi-Porter FM, Westler WM, DeLuca HF, Markley JL.

Biochemistry. 2011 Dec 27;50(51):11025-33. doi: 10.1021/bi201637p. Epub 2011 Dec 5.

Supplemental Content

Loading ...
Support Center